The largest database of trusted experimental protocols

12 protocols using heparin

1

Directed Differentiation of hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The neuroectoderm differentiation was based on Douvaras and Fossati (2015 (link)). In brief, 90% confluent hESCs were subjected to neural induction for 8 days using 100 nM RA (Sigma-Aldrich), 10 μM SB431542 (Tocris), and 250 nM LDN193189 (STEMCELL Technologies). The induction of cardiac progenitor differentiation was based on Lin and Zou (2020 ). hESCs at 80%–90% confluence were treated with 5 mM CHIR99021 (Tocris) for 24 h, after which the cells were cultured in medium with 0.6 U/mL heparin (Sigma-Aldrich) for 24 h. Subsequently, the medium was supplemented with 0.6 U/mL heparin and 3 mM IWP2 (Tocris) for another 3 days. The 8-day depatoblast differentiation was based on Boon et al. (2020 (link)). Differentiation was initiated at 40%–50% confluency, and the hESCs were treated with with 50 ng/mL activin A (STEMCELL Technologies), 50 ng/mL WNT3A (PeproTech), and 6 μL/mL DMSO (Sigma-Aldrich) for 48 h. The cells were incubated for an additional 48 h in the same medium without WNT3A. Then, the medium was changed to contain 50 ng/mL BMP4 (STEMCELL Technologies) and 6 μL/mL DMSO for the following 4 days. More details on the differentiation and the media composition can be found in the supplemental information.
+ Open protocol
+ Expand
2

Tumorsphere Formation Assay for Adherent Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four adherent LA-derived primary cell lines were seeded for tumorsphere formation. StemXVivo serum-free tumorsphere media (cat# CCM012, R&D Systems, Minneapolis, MN, USA) was supplemented with 2U/mL Heparin (cat# 2812, Tocris, Auckland, New Zealand) and 0.5 µg/mL Hydrocortisone (cat# 4093, Tocris Bioscience, Bristol, UK). T75 Nunclon™ Sphera™ EasYFlasks (cat# 174952, ThermoFisher Scientific, Waltham, MA, USA) were seeded with 24 mL of media containing 1 × 104 live cells per mL as determined by cell counting using the Trypan Blue Exclusion method. They were incubated at 37 °C with 5% CO2 for 10 days or until initial signs of dark necrotic centers were observed. Feeding occurred every three to four days by the addition of 12 mL of tumorsphere media. Daily measuring was performed from day three by taking three representative images for each cell line. Five typical sphere-like structures from each image were measured in the longest and shortest dimension, and measurements used to establish a nominal average size for each sphere.
A cell line was considered positive for initial tumorsphere formation if the average sphere size was greater than 50 µm, and if at least 50% of measured spheres were greater than 50 µm, according to previously established criteria [44 (link)].
+ Open protocol
+ Expand
3

Isolation and Culture of Mouse NSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
NSCs were isolated from mouse embryonic cortex (E13.5) and cultured using the method of Reynolds and Weiss [32 (link), 33 (link)], with slight modifications. Briefly, forebrain cortices were cut into small pieces, incubated with accutase (Invitrogen, Carlsbad, CA, USA) and triturated through a 26-gauge needle. The pellets were suspended in growth medium [Dulbecco’s modified Eagle’s medium (DMEM):F-12 medium (DMEM/F12) (Invitrogen) supplemented with epidermal growth factor (EGF, 20 ng/ml), basic fibroblast growth factor (bFGF, 20 ng/ml), leukaemia inhibitory factor (LIF, 10 ng/ml; both from PeproTech, Rocky Hill, NJ, USA), heparin (2.5 μg/ml, Tocris Bioscience, Minneapolis, MN, USA), 2% B27 supplement, l-glutamine (1 mM), penicillin and streptomycin (both 100 U/ml) (all from Invitrogen)]. The cells were incubated in a humidified incubator at 37 °C with 5% CO2, and half the medium was exchanged every 2–3 days. After 5–7 days in vitro, the cells proliferated as free-floating neurospheres. Floating neurospheres were collected and passaged after enzymatic dissociation with accutase and mechanically triturated with fire-polished glass pipettes.
+ Open protocol
+ Expand
4

Tumorsphere Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell was plated in ultralow attachment 6-well plates (Corning) at 25,000 cells per well for primary tumorsphere formation. After incubation for 7 days, mammospheres were collected and dissociated by trypsin. As the secondary tumorsphere formation, 200 cells per well were plated in ultralow attachment 96-well plates. Cells were grown in StemXVivo Serum-Free Media (R&D) containing 2 U/ml Heparin (Tocris) and 0.8 μg/ml Hydrocortisone (Tocris). Mammospheres were harvested 7 days later, and tumorsphere was calculated under inverted phase-contrast light microscope (Olympus). The experiment was repeated three times. Statistical difference on secondary tumorsphere formation was assessed using student T-test with p ≤ 0.05 as the significance criterion.
When the effect of IL6 on tumorsphere formation was examined, recombinant human IL6 (Peprotech) was supplemented at concentration of 0, 100, 200 ng/μl in the beginning of the primary and secondary tumorsphere formation stages.
+ Open protocol
+ Expand
5

Neuroscience Reagent Acquisition Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were purchased from the indicated sources: 1,2,3,4-Tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide (NBQX), D-2-amino-5-phospho-valeric acid (D-APV) and 3-Aminopropyl(diethoxymethyl)phosphonic acid (CGP55845) from the Molecular, Cellular, and Genomic Neuroscience Research Branch (MCGNRB) of the National Institute of Mental Health (NIMH, Bethesda, MD, USA). STO609, U0126, U73122 and wortmannin from Labnet (Madrid, Spain). Leptin, heparin, isoguvacine, nifedipin, QX314, ruthenium red and SKF96365 from Tocris Cookson (Bristol, UK). Tetrodotoxin (TTX) from Abcam (Bristol, UK). 1.2- bis(2-Aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA) and thapsigargin from Sigma (St Louis, MN, USA).
+ Open protocol
+ Expand
6

Tumorsphere Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were suspended in StemXVivo Serum-Free Tumorsphere Media (R&D, USA), supplemented with 2 U/mL heparin (Tocris, USA) and hydrocortisone (Tocris, USA), then seeded at 3×104/well in 6-well ultralow adhesion culture plates (Costar, USA) and cultured at 37 °C with 5% CO2 for 7 days to form tumorspheres.
+ Open protocol
+ Expand
7

Colony Forming Assay for Cell Stemness

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated in 6-well plates at a density of 4×105 cells/well in 2 mL of complete culture medium, and incubated with PAM for 24 h, harvested and dosed. 200 cells were plated in 200 μL StemXVivo Serum-Free Media (R&D) containing 2 U/mL heparin (Tocris), 0.8 μg/mL hydrocortisone (Tocris), 100 U/mL penicillin (Solarbio, Catalog# P1400), and 100 μg/mL streptomycin (Solarbio, Catalog# P1400) in ultra-low adherent 96-well plates (Corning). Colonies were quantified after 7 days.
+ Open protocol
+ Expand
8

Isolation and culture of endothelial progenitor cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the isolation of mononuclear cells (MNCs), ~100 ml of circulating blood was obtained from each patient with DVT or healthy controls using BD Vacutainer EDTA tube (BD Biosciences) and immediately stored in the dark. The samples were processed following collection as follows: MNCs were extracted by density gradient centrifugation using Biocoll (Biochrom, Ltd.) at 5,003 x g at 4˚C for 20 min and washed three times using PBS. Isolated cells were plated on culture dishes that were pre-coated with human fibronectin (Sigma-Aldrich; Merck KGaA) and cultured in endothelial cell growth medium (GE Healthcare Life Sciences) supplemented with bovine brain extract (12 mg/ml), human epidermal growth factor (10 ng/ml), human insulin-like growth factor-1 (50 ng/ml), hydrocortisone (1 mg/ml) and streptomycin (100 µg/ml) and penicillin (100 U/ml; GE Healthcare Life Sciences) at 37˚C. Heparin (10 U/ml; Tocris Bioscience) was used to avoid platelet coagulation and cells were maintained in a humidified 5% CO2 atmosphere at 37˚C. After 3 days, floating cells were aspirated and the culture medium was replaced. EPC colonies formed after 1-2 weeks of culture. Medium was replenished every day for the first 7 days and every other day for the following 7 days. The medium was then replenished every 2-3 days. A total of two batches of cells were used in the subsequent experiments.
+ Open protocol
+ Expand
9

Prostate Cancer Tumorsphere Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prostate cancer cells that were 80–90% confluent were detached with Trypsin-EDTA solution. The cells were centrifuged for 3 minutes at 1200 rpm and the supernatant discarded. The cells were then resuspended in a small volume of StemXVivo-Serum-Free Tumorsphere Media (CCM012) containing 2 U/mL Heparin (Tocris 2812) and 0.8 μg/mL Hydrocortisone (Tocris, 4093). The cells were plated at 0.05 × 106 cells per well in a 6-well ultralow adhesion culture plate and cultured at 37°C and 5% CO2 for 7 days to induce tumorsphere formation as described (Johnson et al., 2013 , Shaheen et al., 2016 ). After 7 days tumorspheres were imaged using a Cytation-3 Imaging Reader from Biotek.
+ Open protocol
+ Expand
10

Characterization of Platelet Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADP (Adenosine 5′-diphosphate sodium), prostacyclin PGI 2 , apyrase, PAF, ACD (acidcitrate-dextrose) anticoagulant and p-chlorophenylalanine (PCPA) were obtained from Sigma Aldrich, TNP (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) -BSA from Santa Cruz, thrombin from Roche, anti-GPIbα (polyclonal rat IgG) and isotype control from Emfret Analytics and heparin from Tocris. Human albumin and fibrinogen were provided by LFB Biomédicaments (2014-01029). Anti-FcγRIIA (mouse IgG2b,
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!